Miraqules
PrivateLast Round
Accelerator
Jul 10, 2023
Est. Valuation
$1.8M
Total Funding Raised
$1.05M
Company Overview
Miraqules is a healthcare and life sciences company that develops and manufactures nano-biopolymer hemostatic solutions for rapid hemorrhage control.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Defense Tech
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miraqules Comparables
Compare Miraqules with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CELOX Medical | 83% | |
| Axio Biosolutions | 79% | |
| Cresilon | 78% |
Miraqules Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 10, 2023 | ||||
| Early Funding | Mar 31, 2022 | ||||
| Grant | Oct 21, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | Jan 1, 2020 | ||||
Grant | Oct 1, 2019 |
Key People
Founding team and executive leadership
Miraqules Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant, Early Funding |
| Defence Research and Development Organisation (DRDO) | Grant |
| MedTech Innovator | Grant |
| MassChallenge Israel | Grant |
| Startup Odisha | Grant |
| Y Combinator | Grant |
| GoAhead Ventures | Pre Seed, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
Will showcase blood clotting technology at TechCrunch Disrupt 2025.
- Mar 31, 2022
$420K raised, led by GoAhead Ventures.
Miraqules Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Miraqules's valuation, stock price, and market status.
Is Miraqules a public or private company?
Miraqules is a private company.
What is the current stock price of Miraqules?
Miraqules is a private company with no public stock price. No recent secondary market data is available.
How much is Miraqules worth (valuation)?
Miraqules's valuation is estimated at $1.8M based on funding round data.
Can I buy Miraqules stock?
Miraqules shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Miraqules's last funding round?
Miraqules's most recent funding round was Accelerator on March 31, 2022.
Who are the main investors in Miraqules?
Key investors in Miraqules include GoAhead Ventures.
Will Miraqules IPO soon?
No public IPO plans have been announced for Miraqules.
How can I track Miraqules secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Miraqules's secondary market activity and sign up for updates.